Tempus AI logo

Director, Business Development - AI Products

Tempus AI

New York, NY; MARemotePosted 12 days ago$150,000 - $200,000/year
Full TimeDirector & AboveCommercial & Pharma SalesAI Biotech
Original posting ↗

Summary

Tempus is a leader in advancing precision medicine through the practical application of artificial intelligence in healthcare. We are seeking a driven and strategic Director of Business Development to drive commercial sales for our AI Products Business unit with a focus on our multi-modal AI and technology portfolio solutions.

Job description

The Business Development Director will identify and pursue new business opportunities, develop and maintain a robust pipeline of prospects and potential customers, and own accounts from lead generation and qualification to proposal writing and deal closure. This role will work with the Paige team and cross functionally with a broad range of stakeholders and will require a strong understanding of the biopharma life cycle. In addition to possessing robust business development skills, ideal candidates will be collaborative, agile team players eager to address and solve significant challenges within the digital pathology, oncology, and biopharma sectors.

Key Responsibilities

  • Drive New Business: Identify and secure new commercial opportunities with Life Sciences partners for Tempus's AI Products business unit, with a focus on our AI and technology portfolio solutions in the imaging and genomics space, including digital pathology
  • Client outreach, development and delivery of materials tailored to the client's needs, client pitches, proposal / SOW writing, and contract negotiations
  • Consultative, Value-Based Selling: Move beyond feature-based selling to articulate a compelling "Why Tempus?" narrative. Focus on the partner's critical business pain and quantify the transformational impact our solutions deliver
  • Strategic Account Planning: Become an expert in the partner's strategy, pipeline and portfolio to proactively determine opportunities where our AI and technology solutions could be leveraged for solving key client challenges
  • Relationship Management: Build and maintain relationships with key executives, strategy and innovation leads, clinical development heads, and program and assets teams
  • Rigorous Deal Qualification and Sales Execution: Qualify opportunities, ensuring a focus on deals with a high probability of success. Identify and engage the Economic Buyer early, build and test champions, and understand the complete decision and contracting process
  • Team-Based Selling: Collaborate closely with internal teams including Product, Engineering, AI Scientists, and Medical teams to present tailored solutions as a unified front to the customer, ensuring technical buy-in and smooth contract execution
  • Pipeline Management: Build and manage a robust sales pipeline in SFDC, providing accurate forecasting and consistently meeting or exceeding revenue targets

Qualifications & Experience

Required

  • 5+ years of demonstrated success in a business development or enterprise sales role within the Life Sciences, biopharma, or health-tech industries
  • Background or strong knowledge of oncology, science, or medical fields
  • Deep understanding of the pharmaceutical R&D and commercialization lifecycle
  • Kind, collaborative, and agile teammate with a desire to tackle and solve meaningful problems within the digital pathology, oncology, and biopharma space
  • Proven track record of exceeding annual sales targets and experience closing complex, multi-year partnerships, service or platform deals
  • Demonstrated ability to establish credibility and build trusted relationships with clients
  • Outstanding communication and presentation skills, with the ability to engage credibly with scientific and executive-level audiences
  • Proactive and adept problem solver with strong prioritization, execution, and critical thinking skills

Preferred

  • Existing relationships within top 20 pharmaceutical companies
  • Experience working in the Digital Pathology and/or modern AI fields (eg, understanding of Foundation Models, AI development)

Requirements

  • 5+ years of demonstrated success in a business development or enterprise sales role within the Life Sciences, biopharma, or health-tech industries
  • Background or strong knowledge of oncology, science, or medical fields
  • Deep understanding of the pharmaceutical R&D and commercialization lifecycle
  • Kind, collaborative, and agile teammate with a desire to tackle and solve meaningful problems within the digital pathology, oncology, and biopharma space
  • Proven track record of exceeding annual sales targets and experience closing complex, multi-year partnerships, service or platform deals
  • Demonstrated ability to establish credibility and build trusted relationships with clients
  • Outstanding communication and presentation skills, with the ability to engage credibly with scientific and executive-level audiences
  • Proactive and adept problem solver with strong prioritization, execution, and critical thinking skills
  • Existing relationships within top 20 pharmaceutical companies
  • Experience working in the Digital Pathology and/or modern AI fields (eg, understanding of Foundation Models, AI development)

Benefits

  • Incentive Compensation
  • Restricted Stock Units
  • Medical Benefits

Company overview

Tempus AI, Inc. (NASDAQ: TEM) is a pioneering healthcare technology company founded in 2015 by Eric Lefkofsky in Chicago, Illinois. The company was established after Lefkofsky's wife was diagnosed with breast cancer, driving his mission to revolutionize cancer care through technology and artificial intelligence. Tempus specializes in applying AI to advance precision medicine by collecting and analyzing vast amounts of molecular, clinical, and genomic data. The company operates across multiple therapeutic areas including oncology, cardiology, radiology, neurology, psychiatry, and dermatology. Tempus provides comprehensive diagnostic services including next-generation sequencing (NGS), PCR profiling, and molecular pathology testing. Its AI-powered platform enables physicians to make real-time, data-driven decisions for personalized patient care and targeted therapies. The company went public in June 2024 and has expanded globally with operations in multiple countries. Tempus continues to innovate at the intersection of healthcare and artificial intelligence, aiming to ensure patients receive the right treatments at the right time for improved health outcomes.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.